Meeder Asset Management Inc Epizyme, Inc. Transaction History

Meeder Asset Management Inc

  • $1.42 Billion
  • Q2 2024

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 11, 2020
SELL
$13.68 - $20.46 $4,870 - $7,283
-356 Closed
0 $0
Q1 2020

May 15, 2020
BUY
$14.83 - $26.72 $2,521 - $4,542
170 Added 91.4%
356 $6,000
Q4 2019

Feb 13, 2020
BUY
$9.77 - $24.6 $1,817 - $4,575
186 New
186 $5,000
Q3 2019

Oct 17, 2019
SELL
$10.17 - $13.86 $1,139 - $1,552
-112 Closed
0 $0
Q2 2019

Aug 05, 2019
SELL
$11.43 - $15.12 $3,600 - $4,762
-315 Reduced 73.77%
112 $1,000
Q1 2019

Apr 16, 2019
BUY
$5.98 - $13.98 $2,553 - $5,969
427 New
427 $5,000
Q2 2018

Jul 24, 2018
SELL
$12.85 - $18.45 $938 - $1,346
-73 Closed
0 $0
Q4 2017

Feb 02, 2018
BUY
$11.55 - $20.1 $358 - $623
31 Added 73.81%
73 $1,000
Q3 2017

Oct 20, 2017
BUY
$12.7 - $19.25 $533 - $808
42
42 $1,000

About Epizyme, Inc.

EPZM Quotes by TradingView
  • Ticker EPZM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 168,364,992
  • Market Cap $247M
More about EPZM
Track This Portfolio

Track Meeder Asset Management Inc Portfolio

Follow Meeder Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Meeder Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email